

| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 430.41 |
| Log P | RDKit | 0.65 |
| Topological polar surface area (Å2) | RDKit | 138.82 |
| Number of hydrogen bond acceptors | RDKit | 9 |
| Number of hydrogen bond donors | RDKit | 4 |
| Number of carbon atoms | RDKit | 22 |
| Number of heavy atoms | RDKit | 31 |
| Number of heteroatoms | RDKit | 9 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 5 |
| Stereochemical complexity | RDKit | 0.23 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 15 |
| Number of sp3 hybridized carbon atoms | RDKit | 7 |
| Shape complexity | RDKit | 0.32 |
| Number of rotatable bonds | RDKit | 5 |
| Number of aliphatic carbocycles | RDKit | 0 |
| Number of aliphatic heterocycles | RDKit | 1 |
| Number of aliphatic rings | RDKit | 1 |
| Number of aromatic carbocycles | RDKit | 2 |
| Number of aromatic heterocycles | RDKit | 1 |
| Number of aromatic rings | RDKit | 3 |
| Total number of rings | RDKit | 4 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 1 |
| Number of saturated rings | RDKit | 1 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 4 |

| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 0 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 0 |
| Ghose filter | RDKit | Passed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Good |
| GSK 4/400 filter | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.459352 |

| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Soluble |
| Solubility class [Silicos-IT] | SwissADME | Soluble |
| Blood Brain Barrier permeation | SwissADME | No |
| Gastrointestinal absorption | SwissADME | High |
| Log Kp (Skin permeation, cm/s) | SwissADME | -8.22 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 0 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | Yes |
| P-glycoprotein substrate | SwissADME | Yes |

| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000756 | ENSG00000109471 | IL2 | 3558 | ChEMBL, NPASS |
| TAR_EXP_000119 | ENSG00000101751 | POLI | 11201 | NPASS |
| TAR_EXP_000417 | ENSG00000111275 | ALDH2 | 217 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000851 | ENSG00000189221 | MAOA | 4128 | ChEMBL |
| TAR_EXP_000456 | ENSG00000085662 | AKR1B1 | 231 | ChEMBL, NPASS |
| TAR_EXP_000852 | ENSG00000069535 | MAOB | 4129 | ChEMBL |
| TAR_EXP_000888 | ENSG00000100985 | MMP9 | 4318 | ChEMBL |
| TAR_EXP_000966 | ENSG00000116044 | NFE2L2 | 4780 | NPASS |
| TAR_EXP_000983 | ENSG00000141458 | NPC1 | 4864 | ChEMBL, NPASS |
| TAR_EXP_001230 | ENSG00000100030 | MAPK1 | 5594 | ChEMBL |
| TAR_EXP_001231 | ENSG00000102882 | MAPK3 | 5595 | ChEMBL |
| TAR_EXP_001240 | ENSG00000169032 | MAP2K1 | 5604 | ChEMBL |
| TAR_EXP_001241 | ENSG00000126934 | MAP2K2 | 5605 | ChEMBL |
| TAR_EXP_001557 | ENSG00000012048 | BRCA1 | 672 | ChEMBL, NPASS |
| TAR_EXP_001621 | ENSG00000141510 | TP53 | 7157 | ChEMBL, NPASS |
| TAR_EXP_001728 | ENSG00000176208 | ATAD5 | 79915 | ChEMBL, NPASS |
| TAR_EXP_001900 | ENSG00000123595 | RAB9A | 9367 | ChEMBL, NPASS |